362 related articles for article (PubMed ID: 34823531)
1. Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims database.
Blin P; Darmon P; Henry P; Guiard E; Bernard MA; Dureau-Pournin C; Maizi H; Thomas-Delecourt F; Lassalle R; Droz-Perroteau C; Moore N
Cardiovasc Diabetol; 2021 Nov; 20(1):229. PubMed ID: 34823531
[TBL] [Abstract][Full Text] [Related]
2. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
Bhatt DL; Steg PG; Mehta SR; Leiter LA; Simon T; Fox K; Held C; Andersson M; Himmelmann A; Ridderstråle W; Chen J; Song Y; Diaz R; Goto S; James SK; Ray KK; Parkhomenko AN; Kosiborod MN; McGuire DK; Harrington RA;
Lancet; 2019 Sep; 394(10204):1169-1180. PubMed ID: 31484629
[TBL] [Abstract][Full Text] [Related]
3. Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
Steg PG; Bhatt DL; Simon T; Fox K; Mehta SR; Harrington RA; Held C; Andersson M; Himmelmann A; Ridderstråle W; Leonsson-Zachrisson M; Liu Y; Opolski G; Zateyshchikov D; Ge J; Nicolau JC; Corbalán R; Cornel JH; Widimský P; Leiter LA;
N Engl J Med; 2019 Oct; 381(14):1309-1320. PubMed ID: 31475798
[TBL] [Abstract][Full Text] [Related]
4. External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry.
Abtan J; Bhatt DL; Elbez Y; Ducrocq G; Goto S; Smith SC; Ohman EM; Eagle KA; Fox K; Harrington RA; Leiter LA; Mehta SR; Simon T; Petrov I; Sinnaeve PR; Pais P; Lev E; Bueno H; Wilson P; Steg PG;
Int J Cardiol; 2023 Jan; 370():51-57. PubMed ID: 36270493
[TBL] [Abstract][Full Text] [Related]
5. Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials.
Leiter LA; Bhatt DL; McGuire DK; Teoh H; Fox K; Simon T; Mehta SR; Lev EI; Kiss RG; Dalby AJ; Bueno H; Ridderstråle W; Himmelmann A; Prats J; Liu Y; Lee JJ; Amerena J; Kosiborod MN; Steg PG;
J Am Coll Cardiol; 2021 May; 77(19):2366-2377. PubMed ID: 33985681
[TBL] [Abstract][Full Text] [Related]
6. Assessment of The High risk and unmEt Need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource use, cost, and burden of illness in a commercially insured population.
Wittbrodt E; Bhalla N; Sundell KA; Hunt P; Wong ND; Kuster M; Mellström C
J Diabetes Complications; 2021 Apr; 35(4):107859. PubMed ID: 33558152
[TBL] [Abstract][Full Text] [Related]
7. Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCI.
Ducrocq G; Bhatt DL; Lee JJ; Kui N; Fox KM; Harrington RA; Leiter LA; Mehta SR; Kiss RG; James S; Vinereanu D; Huber K; Andersson M; Himmelmann A; Simon T; Steg PG
Am Heart J; 2022 Jul; 249():23-33. PubMed ID: 35321823
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and design.
Mohammedi K; Préaubert N; Cariou T; Rigalleau V; Foussard N; Piazza L; Bairras-Martin C; Couffinhal T; Bezin J; Benard A
Cardiovasc Diabetol; 2021 Mar; 20(1):63. PubMed ID: 33714278
[TBL] [Abstract][Full Text] [Related]
9. Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study.
Bhatt DL; Fox K; Harrington RA; Leiter LA; Mehta SR; Simon T; Andersson M; Himmelmann A; Ridderstråle W; Held C; Steg PG;
Clin Cardiol; 2019 May; 42(5):498-505. PubMed ID: 30788847
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Bach RG; Brooks MM; Lombardero M; Genuth S; Donner TW; Garber A; Kennedy L; Monrad ES; Pop-Busui R; Kelsey SF; Frye RL;
Circulation; 2013 Aug; 128(8):785-94. PubMed ID: 23857320
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the high risk and unmet need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource utilization, cost and burden of illness in the Diabetes Collaborative Registry.
Wittbrodt E; Bhalla N; Andersson Sundell K; Gao Q; Dong L; Cavender MA; Hunt P; Wong ND; Mellström C
Endocrinol Diabetes Metab; 2020 Jul; 3(3):e00133. PubMed ID: 32704557
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study.
Zhao Q; Wang L; Kurlansky PA; Schein J; Baser O; Berger JS
BMC Cardiovasc Disord; 2019 Jan; 19(1):19. PubMed ID: 30646855
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial.
Steg PG; Bhatt DL; James SK; Darlington O; Hoskin L; Simon T; Fox KM; Leiter LA; Mehta SR; Harrington RA; Himmelmann A; Ridderstråle W; Andersson M; Bueno H; De Luca L; Tank A; Mellström C; McEwan P
Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 8(8):777-785. PubMed ID: 35488865
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database.
Blin P; Joubert M; Jourdain P; Zaoui P; Guiard E; Sakr D; Dureau-Pournin C; Bernard MA; Lassalle R; Thomas-Delecourt F; Bineau S; Moore N; Droz-Perroteau C
Cardiovasc Diabetol; 2024 Jan; 23(1):22. PubMed ID: 38195491
[TBL] [Abstract][Full Text] [Related]
15. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims database.
Blin P; Dureau-Pournin C; Lassalle R; Jové J; Thomas-Delecourt F; Droz-Perroteau C; Danchin N; Moore N
Br J Clin Pharmacol; 2017 Sep; 83(9):2056-2065. PubMed ID: 28345154
[TBL] [Abstract][Full Text] [Related]
17. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
[TBL] [Abstract][Full Text] [Related]
18. Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population.
Kern DM; Mellström C; Hunt PR; Tunceli O; Wu B; Westergaard M; Hammar N
Curr Med Res Opin; 2016; 32(4):703-11. PubMed ID: 26709864
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and outcomes of COMPASS eligible patients in France. An analysis from the REACH Registry.
Darmon A; Elbez Y; Bhatt DL; Abtan J; Mas JL; Cacoub P; Montalescot G; Billaut-Laden I; Ducrocq G; Steg PG
Ann Cardiol Angeiol (Paris); 2020 Oct; 69(4):158-166. PubMed ID: 32778388
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients.
Ducluzeau PH; Fauchier G; Herbert J; Semaan C; Halimi JM; Angoulvant D; Fauchier L
Diabetes Metab; 2023 May; 49(3):101429. PubMed ID: 36736892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
